These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12065883)

  • 1. Service-based survey of dystonia in munich.
    Castelon Konkiewitz E; Trender-Gerhard I; Kamm C; Warner T; Ben-Shlomo Y; Gasser T; Conrad B; Ceballos-Baumann AO
    Neuroepidemiology; 2002; 21(4):202-6. PubMed ID: 12065883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey.
    Cossu G; Mereu A; Deriu M; Melis M; Molari A; Melis G; Minafra L; Pisano T; Cianchetti C; Ortu E; Sau G; Aiello I; Fresu M; Marrosu MG; Contu P
    Mov Disord; 2006 Nov; 21(11):2005-8. PubMed ID: 16960861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of dystonias].
    Marion MH
    Presse Med; 1999 Feb; 28(6):312-5. PubMed ID: 10073178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prevalence study of primary dystonia in eight European countries.
    Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group
    J Neurol; 2000 Oct; 247(10):787-92. PubMed ID: 11127535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of primary focal or segmental dystonia in adults in the district of foggia, southern Italy: a service-based study.
    Papantonio AM; Beghi E; Fogli D; Zarrelli M; Logroscino G; Bentivoglio A; Simone P; Tonali P; Specchio LM
    Neuroepidemiology; 2009; 33(2):117-23. PubMed ID: 19556806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of focal and generalized dystonia in Rochester, Minnesota.
    Nutt JG; Muenter MD; Aronson A; Kurland LT; Melton LJ
    Mov Disord; 1988; 3(3):188-94. PubMed ID: 3264051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxins in the treatment of primary focal dystonias.
    Truong D
    J Neurol Sci; 2012 May; 316(1-2):9-14. PubMed ID: 22336699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: Comparison with prevalence evaluated in 1993.
    Fukuda H; Kusumi M; Nakashima K
    Mov Disord; 2006 Sep; 21(9):1503-6. PubMed ID: 16755586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects and therapy of dystonias].
    Huber M
    Fortschr Neurol Psychiatr; 1995 Mar; 63(3):99-105. PubMed ID: 7759050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical spectrum of laryngeal dystonia includes dystonic cough: observations of a large series.
    Payne S; Tisch S; Cole I; Brake H; Rough J; Darveniza P
    Mov Disord; 2014 May; 29(6):729-35. PubMed ID: 24753288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dystonia: their epidemiology, aetiology, diagnosis and treatment].
    Rodríguez-Constela I; Rodríguez-Regal A; Cebrián-Pérez EM
    Rev Neurol; 2009 Jan; 48 Suppl 1():S61-9. PubMed ID: 19222018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in Ireland.
    Williams L; McGovern E; Kimmich O; Molloy A; Beiser I; Butler JS; Molloy F; Logan P; Healy DG; Lynch T; Walsh R; Cassidy L; Moriarty P; Moore H; McSwiney T; Walsh C; O'Riordan S; Hutchinson M
    Eur J Neurol; 2017 Jan; 24(1):73-81. PubMed ID: 27647704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystonia: medical therapy and botulinum toxin.
    Jankovic J
    Adv Neurol; 2004; 94():275-86. PubMed ID: 14509685
    [No Abstract]   [Full Text] [Related]  

  • 18. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
    Jankovic J
    Adv Neurol; 1988; 50():583-91. PubMed ID: 3041763
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.